Investors with a lot of money to spend have taken a bearish stance on Teva Pharmaceutical Indus (NYSE:TEVA). And retail traders should know. We noticed this today when the trades showed up on ...

Looking ahead, revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 8.6% growth forecast for the Pharmaceuticals industry in the US.

There are plenty of renewal appointments available. Also, those who don't have a NJ driver's license can get a REAL ID through a non-driver ID appointment or an out-of-state transfer appointment.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

New Jersey Democratic gubernatorial candidates during the Garden State’s first primary debate of the year vowed to help illegal immigrants avoid President Trump’s ICE raids. Five out of six ...

NJ Cancels Offshore Wind Solicitation as Industry Struggles Move comes after Shell bows out of Atlantic Shores project Inflation, Trump opposition increase strain on wind developers ...

Shares of NYSE TEVA opened at $17.81 on Thursday. Teva Pharmaceutical Industries has a 12 month low of $11.62 and a 12 month high of $22.80. The company has a market cap of $20.17 billion, a P/E ...

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug Administration (FDA). The company’s "first-in-class" suzetrigine pain pill ...

JOSEPH PREZIOSO / AFP via Getty Images Vertex Pharmaceuticals' non-opioid painkiller received approval from the Food and Drug Administration. The drugmaker said the twice-daily pill, Journavx ...

Elizabeth (12-4) gets revenge after a 72-60 loss to Roselle Catholic on Jan. 7. Elizabeth has gone 5-3 in the eight games since that loss. No. 2 Plainfield leads the Watchung Division of the Union ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...